Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration

Detalles Bibliográficos
Autores principales: Weesner, Elizabeth, Ghassemi, Hosain, Salapenka, Iryna, Konakanchi, Jaya Sri, Maggio, Gregory, Sethi, Roopa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Kansas Medical Center 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409986/
https://www.ncbi.nlm.nih.gov/pubmed/36042837
http://dx.doi.org/10.17161/kjm.vol15.17931
_version_ 1784774984579678208
author Weesner, Elizabeth
Ghassemi, Hosain
Salapenka, Iryna
Konakanchi, Jaya Sri
Maggio, Gregory
Sethi, Roopa
author_facet Weesner, Elizabeth
Ghassemi, Hosain
Salapenka, Iryna
Konakanchi, Jaya Sri
Maggio, Gregory
Sethi, Roopa
author_sort Weesner, Elizabeth
collection PubMed
description
format Online
Article
Text
id pubmed-9409986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher University of Kansas Medical Center
record_format MEDLINE/PubMed
spelling pubmed-94099862022-08-29 Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration Weesner, Elizabeth Ghassemi, Hosain Salapenka, Iryna Konakanchi, Jaya Sri Maggio, Gregory Sethi, Roopa Kans J Med Case Report University of Kansas Medical Center 2022-08-22 /pmc/articles/PMC9409986/ /pubmed/36042837 http://dx.doi.org/10.17161/kjm.vol15.17931 Text en © 2022 The University of Kansas Medical Center https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Report
Weesner, Elizabeth
Ghassemi, Hosain
Salapenka, Iryna
Konakanchi, Jaya Sri
Maggio, Gregory
Sethi, Roopa
Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
title Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
title_full Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
title_fullStr Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
title_full_unstemmed Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
title_short Injection Site Reaction to Extended-Release Buprenorphine (Sublocade(®)) for Opioid Use Disorder Fourteen Days after Administration
title_sort injection site reaction to extended-release buprenorphine (sublocade(®)) for opioid use disorder fourteen days after administration
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409986/
https://www.ncbi.nlm.nih.gov/pubmed/36042837
http://dx.doi.org/10.17161/kjm.vol15.17931
work_keys_str_mv AT weesnerelizabeth injectionsitereactiontoextendedreleasebuprenorphinesublocadeforopioidusedisorderfourteendaysafteradministration
AT ghassemihosain injectionsitereactiontoextendedreleasebuprenorphinesublocadeforopioidusedisorderfourteendaysafteradministration
AT salapenkairyna injectionsitereactiontoextendedreleasebuprenorphinesublocadeforopioidusedisorderfourteendaysafteradministration
AT konakanchijayasri injectionsitereactiontoextendedreleasebuprenorphinesublocadeforopioidusedisorderfourteendaysafteradministration
AT maggiogregory injectionsitereactiontoextendedreleasebuprenorphinesublocadeforopioidusedisorderfourteendaysafteradministration
AT sethiroopa injectionsitereactiontoextendedreleasebuprenorphinesublocadeforopioidusedisorderfourteendaysafteradministration

Ejemplares similares